Stay updated on VAX-24 Safety and Immunogenicity in Adults Clinical Trial
Sign up to get notified when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.

Latest updates to the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page
- Check5 days agoChange DetectedA sitewide NIH notice about a terminology transition appeared, and the displayed site revision changed from v3.7.1 to v3.7.2. The study page continues to show a 403 error rather than trial details.SummaryDifference1%

- Check12 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check32 days agoChange DetectedThe study record page now shows a 403 Forbidden error instead of the study details. This indicates restricted access or a server-side access problem affecting how the record is displayed.SummaryDifference19%

- Check39 days agoChange DetectedThe page revision label updated from v3.6.6 to v3.7.0, signaling a new version of the study details page. This update appears to be a metadata/version change rather than a substantive alteration to the study data or descriptions.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page now displays Revision: v3.6.6 instead of v3.6.5, signaling a small system update rather than a change to the study details.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.6.5 is now displayed in the page footer, replacing v3.6.4. This change updates the page metadata without affecting the study details or results.SummaryDifference0.0%

Stay in the know with updates to VAX-24 Safety and Immunogenicity in Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.